Comparing two biopsy methods for lung cancer genetic testing
Part of Cancer, Lungs & breathing clinical trials.
This study compares two ways to get a larger tissue sample from lymph nodes in the chest after a first small test confirmed cancer. The goal is to see which method provides better material for detailed genetic testing (next generation sequencing) that can guide treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a spot in your lung or chest lymph nodes (seen on a PET or CT scan) that your doctor thinks might be cancer or a cancer that has spread from elsewhere.
- The first small sample (taken during a quick look with a scope) must have shown cancer cells.
- You must be 18 years or older.
- You must not be pregnant.
- You must not be in prison.
- Your doctor must decide it is safe to biopsy the spot.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether it’s practical to do gene (DNA) testing on samples taken during EBUS-TBNA, a common breathing-tube biopsy used to stage lung cancer. If it works well, it could make genetic testing faster and easier for people with lung cancer.
This trial looks at using a scope with an ultrasound tip (EBUS-TBNA) to take small tissue samples from lymph nodes to figure out the cancer stage before stereotactic body radiotherapy (SBRT). The goal is to help confirm how far the cancer has spread so SBRT can be planned appropriately.
This trial compares two ways of collecting tissue samples from lymph nodes in the chest during a procedure called EBUS-TBNA. The goal is to see if changing the needle during the procedure gives better results for diagnosing lung cancer.
This trial compares two ways to take tissue samples from swollen lymph nodes in the chest. The goal is to see if a newer technique called EBUS-TTFB gets better samples than the standard method (EBUS-TBNA) when the first samples aren't enough.
This trial tests if a newer, freezing biopsy method (cryobiopsy) is better than standard needle biopsy for diagnosing lymphoma in lymph nodes between the lungs. It could help avoid more invasive surgeries.
This study compares two ways of doing a lung biopsy with a needle guided by ultrasound. It aims to see which method gives better samples for diagnosing lung cancer.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.